HOME >> BIOLOGY >> NEWS
Study in Science reveals recreational fishing takes big bite of ocean catch

U.S. saltwater recreational fishing catch rivals commercial fisheries for many depleted fish stocks including red snapper, black seabass, and lingcod

Taking a hard look at the common belief that recreational fishing accounts for only 2-3% of total landings in the U.S., a new study published in the journal Science (August 26th) reveals that recreational catches account for nearly a quarter of the total take of over fished populations, including many of the most economically valuable species such as red snapper, red drum, lingcod, and bocaccio.

For specific depleted populations in the U.S.--particularly the large charismatic fishes that people care about most--recreational landings outstrip commercial landings. This is true for red snapper (59% recreational) and gag (56%) in the Gulf of Mexico, red drum in the South Atlantic (93%), and bocaccio on the Pacific coast (87%), among others.

"The conventional wisdom is that recreational fishing is a small proportion of the total take, so it is largely overlooked," says lead author Felicia Coleman of Florida State University. "But if you remove the fish caught and used for fish sticks and fishmeal (pollock and menhaden) two strictly commercially caught species that account for over half of all U.S. landings - the recreational take rises to 10% nationally. And if you focus in on the populations identified by the Federal government as species of concern, it rises to 23%."

The study is the first comprehensive analysis of the impact of recreational saltwater fishing in the U.S. Using all available federal and state data, the authors formally compare commercial and recreational landings for the past 22 years - first for all federally managed fish, and then for species of concern (species officially classified by the National Marine Fisheries Service as "over-fished" or "experiencing over-fishing") both nationally and regionally. The Pew Charitable Trusts, one of the U.S.'s largest philanth
'"/>

Contact: Jessica Brown
jbrown@seaweb.org
202-497-8375
SeaWeb
26-Aug-2004


Page: 1 2 3 4 5

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study suggests cell-cycle triggers might be cancer drug targets
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. Study links high carbohydrate diet to increased breast cancer risk
10. Study explains spatial orientation differences between sexes
11. Study suggests humans can speed evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... Over the ... into their drug discovery research workflows with biology ranging from single cell-type spheroids ... of in vitro studies, they create several challenges that need to be overcome ...
(Date:12/27/2018)... FRANCISCO (PRWEB) , ... December 27, 2018 , ... ... annual Microbiome Conference at JPM as part of the JP Morgan 37th Annual ... innovative scientists and physicians, and members of the investment community. , Since ...
(Date:12/20/2018)... ... December 20, 2018 , ... Human Factors and product ... a new usability/observation room. This addition will help meet the increased industry demand ... delivery devices/combination products are safe and easy to use when released to the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/7/2019)... SEONGNAM, South Korea (PRWEB) , ... January 07, ... ... has completed Phase 1 clinical trials of its Parkinson's Disease drug candidate, code-named ... disease-modifying treatment of Parkinson's Disease. The trial took place in South Korea. ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
Breaking Biology Technology:
Cached News: